Showing results (191-200 of 623) with videos related to
Sort By:
Pageof 63
Scientific Reports|December 3, 2017
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes MellitusConstantin Lapa, Paula Arias-Loza, Nobuyuki Hayakawa, et al.The Lancet. Oncology|March 6, 2020
Radiotheranostics: a roadmap for future developmentKen Herrmann, Markus Schwaiger, Jason S Lewis, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 3, 2019
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trialMaja Guberina, Wilfried Eberhardt, Martin Stuschke, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2014
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancerChristina Bluemel, Ken Herrmann, Alexander Kübler, et al.Oncotarget|March 4, 2016
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapyConstantin Lapa, Heribert Hänscheid, Vanessa Wild, et al.European Urology Oncology|March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic ReviewAndrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Diagnostic Accuracy of [18F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and MetaanalysisAkram Al-Ibraheem, Ahmed Abdlkadir, Ken Herrmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junctionKatja Ott, Wolfgang A Weber, Florian Lordick, et al.Neuro-Oncology|December 6, 2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patientsKen Herrmann, Johannes Czernin, Timothy Cloughesy, et al.Plos One|July 7, 2017
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumineJulian Kirchner, Lino M Sawicki, Cornelius Deuschl, et al.Pageof 63